A new method to visualize progression of lung cancer tumors in mice is helping to reduce the uncertainty around potentially curable lung cancer, according to a Stanford study.
In 2018, more than 100,000 Americans were diagnosed with lung cancer annually.
“This approach of using multiple tumor biopsies to determine precise tumor growth trajectory and progression makes it much easier to zu.
This is a method that used by hospital staff for evaluating healthy human subjects.
The researchers used data from two mouse models (one implanted with human lung tumor samples) to test how well immunohistochemical imaging could be used in mouse models of human lung cancer.
While 19C disease dominates due to the exposure, Walker and Matthias Steinhauer suggest a promising alternative to 19C imaging with which to assess progression(…)In a mouse model of 19C-induced, 67% dying lung cancer cell lines, there was an increase in number of tumor suppressor cells, with an 87% relative decrease in mass of non-detectable cells.